Gala Pharmaceutical Inc. (CIK: 0001513403) EDGAR, Information, Filings... CompaniesBIO.Com

Gala Pharmaceutical Inc.

Mailing address
18881 VON KARMAN AVE., SUITE 1440, IRVINE, Nevada, 92612
Phone
949-851-9261
State location
California
State of incorporation
Nevada
Fiscal year end
November 30
SIC
2300 - (CF Office: Office of Manufacturing) APPAREL & OTHER FINISHD PRODS OF FABRICS & SIMILAR MATL
Filings
N/A

Gala Pharmaceutical Inc. (CIK: 0001513403) is an American company incorporated in the state of California. Head office is located at 18881 VON KARMAN AVE., SUITE 1440, IRVINE, California, 92612. Work in the industry 2300 - (CF Office: Office of Manufacturing) APPAREL & OTHER FINISHD PRODS OF FABRICS & SIMILAR MATL. Gala Pharmaceutical Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Gala Pharmaceuticals Inc. from 2018-28-Feb to 2018-20-Jul
Gala Global Inc. from 2011-11-Mar to 2018-05-Jan

Owner	Filings	Transaction Date	Type of Owner
HAAS JAMES	0001240901	Nov-30-2018	10 percent owner
Naccarato Owen	0001417684	Nov-30-2018	10 percent owner
Rehman Maqsood	0001771990	Nov-30-2018	director, officer: CEO
Makkar Mohan Singh	0001773555	Nov-30-2018	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Gala Pharmaceutical Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
REVOKED	Document	Acc-no: 9999999997-21-004648 (34 Act) Size: 285 KB	Sep-07-2021	000-55998 211238550
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001567619-21-011844 (34 Act) Size: 96 KB	Jun-08-2021	005-90476 211003012
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001567619-20-011668 (34 Act) Size: 96 KB	Jun-04-2020	005-90476 20942111
8-K	Document	Current report filing Acc-no: 0001683168-20-001378 (34 Act) Size: 29 KB	May-04-2020	000-55998 20842455
8-K	Document	Current report filing Acc-no: 0001683168-19-003296 (34 Act) Size: 37 KB	Oct-21-2019	000-55998 191158600
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001683168-19-003265 (34 Act) Size: 19 KB	Oct-16-2019	000-55998 191152625
8-K/A	Document	Amendment to Current report filing Acc-no: 0001683168-19-002753 (34 Act) Size: 96 KB	Aug-26-2019	000-55998 191050365
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001683168-19-002291 (34 Act) Size: 2406 KB	Jul-23-2019	000-55998 19968099
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001683168-19-002184 (34 Act) Size: 20 KB	Jul-15-2019	000-55998 19953840
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001567619-19-011688 (34 Act) Size: 96 KB	May-21-2019	005-90476 19840165
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001683168-19-001231 (34 Act) Size: 2178 KB	Apr-30-2019	000-55998 19777778
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0001683168-19-001131 ( Act) Size: 9 KB	Apr-19-2019
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0001683168-19-001130 ( Act) Size: 9 KB	Apr-19-2019
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0001683168-19-001090 ( Act) Size: 7 KB	Apr-17-2019
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0001683168-19-001087 ( Act) Size: 7 KB	Apr-17-2019
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001683168-19-001083 (34 Act) Size: 19 KB	Apr-17-2019	000-55998 19752049
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001683168-19-001047 (34 Act) Size: 3096 KB	Apr-15-2019	000-55998 19749069
8-K	Document	Current report filing Acc-no: 0001683168-19-000724 (34 Act) Size: 16 KB	Mar-20-2019	000-55998 19692992
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001683168-19-000510 (34 Act) Size: 19 KB	Feb-28-2019	000-55998 19639923
8-K	Document	Current report filing Acc-no: 0001683168-19-000091 (34 Act) Size: 30 KB	Jan-14-2019	000-55998 19525057

Recent 20 filings. View all Gala Pharmaceutical Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Gala Pharmaceutical Inc. overview
Gala Pharmaceutical Inc. job
Gala Pharmaceutical Inc. stock
Gala Pharmaceutical Inc. ownership
Gala Pharmaceutical Inc. CEO
Gala Pharmaceutical Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.